The epigenetic modulation of αVβ3 integrin might be involved in melanoma progression, furthermore, latexin (a negative regulator of HSCs) is downregulated in one-out-of-two melanomas, with its promoter region hypermethylated in melanomas and other cancers [34]. This evidence concerns the gene LXN and melanoma.